Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020

Published by
Matej Mikulic,
Aug 3, 2020
Oncology was the therapeutic area with the largest potential in M&A value of protfolio optimization, as of early 2020. The potential deal multiplier stood at six, with a potential asset value of 84 billion U.S. dollars. This statistic illustrates the life sciences M&A value of portfolio optimization worldwide as of 2020, by five selected therapeutic areas.

Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

January 2020

Region

Worldwide

Survey time period

as of January 2020

Number of respondents

base: 30 leading life sciences companies

Supplementary notes

Modeling assumes assets are divestiture candidates if owners’ revenues total 3% or less of total therapy area revenues.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Biotechnology in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology in Spain

Global overview

6

Main figures

6

Companies

6

Areas of application

6

R&D investment

6

Funding

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in SpainGlobal pharmaceutical industryBiotech drugsBiotechnology industry in Germany Biotechnology in Europe
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu